A natural choice for hemophilia B.
Publication
, Journal Article
Koeberl, DD
Published in: Blood
March 5, 2015
In this issue of Blood, Crudele et al describe a novel study of adeno-associated virus (AAV) vector-mediated gene therapy that induced immune tolerance to factor IX (FIX) in a hemophilia B (HB) dog with previously formed anti-FIX inhibitor antibodies (IAs).
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
March 5, 2015
Volume
125
Issue
10
Start / End Page
1509 / 1510
Location
United States
Related Subject Headings
- Male
- Immunology
- Humans
- Hemophilia B
- Genetic Therapy
- Factor IX
- Animals
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Koeberl, D. D. (2015). A natural choice for hemophilia B. Blood, 125(10), 1509–1510. https://doi.org/10.1182/blood-2015-01-622506
Koeberl, Dwight D. “A natural choice for hemophilia B.” Blood 125, no. 10 (March 5, 2015): 1509–10. https://doi.org/10.1182/blood-2015-01-622506.
Koeberl DD. A natural choice for hemophilia B. Blood. 2015 Mar 5;125(10):1509–10.
Koeberl, Dwight D. “A natural choice for hemophilia B.” Blood, vol. 125, no. 10, Mar. 2015, pp. 1509–10. Pubmed, doi:10.1182/blood-2015-01-622506.
Koeberl DD. A natural choice for hemophilia B. Blood. 2015 Mar 5;125(10):1509–1510.
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
March 5, 2015
Volume
125
Issue
10
Start / End Page
1509 / 1510
Location
United States
Related Subject Headings
- Male
- Immunology
- Humans
- Hemophilia B
- Genetic Therapy
- Factor IX
- Animals
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology